DE2262787C2 - Antibakterielles Mittel - Google Patents

Antibakterielles Mittel

Info

Publication number
DE2262787C2
DE2262787C2 DE2262787A DE2262787A DE2262787C2 DE 2262787 C2 DE2262787 C2 DE 2262787C2 DE 2262787 A DE2262787 A DE 2262787A DE 2262787 A DE2262787 A DE 2262787A DE 2262787 C2 DE2262787 C2 DE 2262787C2
Authority
DE
Germany
Prior art keywords
fluoro
cycloserine
concentration
alanln
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2262787A
Other languages
German (de)
English (en)
Other versions
DE2262787A1 (de
Inventor
Frederick Marvin Rahway N.J. Kahan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2262787A1 publication Critical patent/DE2262787A1/de
Application granted granted Critical
Publication of DE2262787C2 publication Critical patent/DE2262787C2/de
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE2262787A 1972-02-03 1972-12-21 Antibakterielles Mittel Expired DE2262787C2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22336072A 1972-02-03 1972-02-03
US31487872A 1972-12-13 1972-12-13

Publications (2)

Publication Number Publication Date
DE2262787A1 DE2262787A1 (de) 1973-08-09
DE2262787C2 true DE2262787C2 (de) 1982-09-23

Family

ID=26917692

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2262787A Expired DE2262787C2 (de) 1972-02-03 1972-12-21 Antibakterielles Mittel

Country Status (9)

Country Link
BE (1) BE794913A (cs)
CA (1) CA1024448A (cs)
DE (1) DE2262787C2 (cs)
FR (1) FR2181703B1 (cs)
GB (1) GB1421023A (cs)
HK (1) HK86479A (cs)
IE (1) IE37134B1 (cs)
IL (1) IL41358A (cs)
NL (1) NL177183C (cs)

Also Published As

Publication number Publication date
BE794913A (fr) 1973-08-02
GB1421023A (en) 1976-01-14
FR2181703A1 (cs) 1973-12-07
DE2262787A1 (de) 1973-08-09
NL177183B (nl) 1985-03-18
IL41358A (en) 1976-03-31
IL41358A0 (en) 1973-03-30
CA1024448A (en) 1978-01-17
FR2181703B1 (cs) 1975-11-21
NL7300636A (cs) 1973-08-07
IE37134L (en) 1973-08-03
HK86479A (en) 1979-12-28
IE37134B1 (en) 1977-05-11
NL177183C (nl) 1985-08-16

Similar Documents

Publication Publication Date Title
DE2250993C2 (de) Antibakterielles Mittel
EP0240829A2 (de) Cancerostatisches Mittel
DE2631947A1 (de) Konservierung von basischen arzneimittelzubereitungen
EP0460622B1 (de) Arzneimittelzubereitung zur systemischen Behandlung von Zier- und Nutzfischen
EP0655249A1 (de) Moenomycin als Arzneimittel zur Behandlung von Magengeschwüren
DE2262787C2 (de) Antibakterielles Mittel
CH677608A5 (cs)
DE1237107B (de) Verfahren zur Herstellung von Tetracyclinfusidat, des Salzes der Fusidinsaeure mit Tetracyclin
DE3785953T2 (de) Bakterientötende Gemische.
EP0462506B1 (de) Pharmazeutische Kombinationspräparate enthaltend Cefotaxim und Xanthinderivate und deren Verwendung
DE2312134C2 (de) Anthelmintikum
DE3104282C2 (cs)
DE3618813A1 (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen
DE2448564C3 (de) Verwendung von heterocyclischen Carbonsäuren
DE2436959C2 (de) Antibakterielle zusammensetzung mit einem gehalt an einer verbindung vom 3-fluor-d-alanin-typ und einer n-substituierten cycloserinverbindung
DE69528922T2 (de) Herstellung von 2-Bromo-5-(2-bromo-2-nitro-vinyl)-furan und deren Verwendung als Microzide
DE1963223A1 (de) Mittel zur Behandlung von Virusinfektionen
DE2522081C2 (cs)
DE1792223C3 (de) Arzneipräparate, geeignet zur Behandlung von durch gramnegative Bakterien hervorgerufenen Infektionen
EP0152860B1 (de) Verwendung von Cephemverbindungen zur Herstellung eines Arzneimittels für die Modulation des Immunsystems
EP0304897A2 (de) Mittel zur Immunisierung des menschlichen Körpers bei HIV-Infektionen
DE2760340C2 (cs)
DE1219937B (de) Verfahren zur Herstellung des antibakteriell wirksamen 1-Methyl-3-carboxy-6, 7-dimethoxy-4-(1H)-chinolons
AT392903B (de) Pharmazeutische zubereitung enthaltend ein cephalosporin und ein penemantibiotikum
DE2259624C3 (de) Antibakterielles Arzneimittel

Legal Events

Date Code Title Description
OD Request for examination
D2 Grant after examination